SCHEMBL4826784

SCHEMBL4826784

CC(C)(C)OC(=O)N1CCN(c2ccc(CCC(=O)N3CCOCC3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 3/20 0.58
MAPT P10636 5/20 0.56
ALDH1A1 P00352 3/20 0.56
LMNA P02545 2/20 0.56
NPSR1 Q6W5P4 2/20 0.54
SMN1; SMN2 Q16637 5/20 0.53
USP2 O75604 1/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
CYP2C19 P33261 1/20 0.53
ME2 P23368 2/20 0.52
ME1 P48163 2/20 0.52
ME3 Q16798 2/20 0.52
HTT P42858 1/20 0.52
GFER P55789 1/20 0.51
DDB1 Q16531 1/20 0.48
CRBN Q96SW2 1/20 0.48
GPR119 Q8TDV5 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826310 0.83 SIGMAR1 (0.54) MAPTALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL1722245 0.82 SMN1; SMN2 (0.57) MAPTALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL3709870 0.82 MAPT (0.61) MAPTALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL23355487 0.82 MAPT (0.61) MAPTALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL27889137 0.81 FKBP1A (0.52) FKBP1AMAPTALDH1A1LMNANPSR1
SCHEMBL19212323 0.81 MAPT (0.60) MAPTALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL19144654 0.81 L3MBTL1 (0.53) FKBP1AMAPTALDH1A1LMNAHTT
SCHEMBL22031555 0.80 L3MBTL1 (0.71) FKBP1AMAPTALDH1A1LMNAMEN1
SCHEMBL18210853 0.80 SMN1; SMN2 (0.54) MAPTALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL5573222 0.80 MAPT (0.76) MAPTALDH1A1LMNANPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449485-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES INC. (US) 2008-11-11 US disclosed
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-06-19 US disclosed
US-7358251-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES (US) 2008-04-15 US disclosed
EP-1487811-B1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LAB (US) 2007-09-05 EP disclosed
US-7030115-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES (US) 2006-04-18 US disclosed
US-20060074085-A1 N-sulfonylurea apoptosis promoters ABBVIE INC. 2006-04-06 US disclosed
US-20030236247-A1 N-sulfonylurea apoptosis promoters ABBVIE INC. 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS BAX, BCL2, BAD FKBP1A 1833/4885MAPT 4694/4885ALDH1A1 1945/4885
US-20060074085-A1 N-sulfonylurea apoptosis promoters BAX, BCL2, BAD FKBP1A 1833/4885MAPT 4694/4885ALDH1A1 1945/4885
US-20030236247-A1 N-sulfonylurea apoptosis promoters BAX, BCL2, AIFM1 FKBP1A 1624/4885MAPT 4735/4885ALDH1A1 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.